Postoperative outcomes of drug-eluting sinus implants versus oral methylprednisolone after functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps

Background Drug-eluting sinus implants provide sustained local corticosteroid delivery after functional endoscopic sinus surgery (FESS), but comparative evidence relative to systemic corticosteroid therapy remains limited. This study aimed to compare postoperative outcomes between these strategies in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Methods This retrospective cohort included 129 patients treated between January 2022 and December 2024. Patients were classified into the drug-eluting sinus implant group, which underwent FESS with drug-eluting sinus implants (n = 68), and the oral methylprednisolone group, which underwent FESS followed by a 15-day oral methylprednisolone taper (n = 61). Both groups received the same routine postoperative care. The primary outcome was longitudinal change in the Sino-Nasal Outcome Test-22 (SNOT-22) score through Month 12. Secondary outcomes included visual analog scale (VAS) symptom scores, endoscopic healing outcomes, postoperative complications, and steroid-related adverse events. Biomarker changes were exploratory outcomes. Results SNOT-22 scores improved in both groups. At Month 12, the model-based between-group difference in change was −11.86 points (95% confidence interval [CI], −14.82 to −8.90; Holm-adjusted P < 0.001), with a similar multivariable-adjusted estimate (−11.32 points; 95% CI, −14.61 to −8.04; P < 0.001). Improvements in all five VAS symptom domains were greater in the drug-eluting sinus implant group after multiplicity correction. Compared with the oral methylprednisolone group, the drug-eluting sinus implant group had lower adjusted odds of synechiae or adhesion at Month 3 (adjusted odds ratio [OR], 0.09; 95% CI, 0.02–0.43) and ostial stenosis or obstruction at Month 6 (adjusted OR, 0.20; 95% CI, 0.06–0.65). Steroid-related adverse events occurred in 2.9% of patients in the drug-eluting sinus implant group and 16.4% of those in the oral methylprednisolone group (P = 0.013). Most inflammatory and type 2 biomarkers showed greater reductions at Month 3 in the drug-eluting sinus implant group after false discovery rate correction. Conclusion Compared with oral methylprednisolone, drug-eluting sinus implants was associated with greater symptom improvement, more favorable postoperative healing outcomes, fewer steroid-related adverse events, and greater reductions in several inflammatory biomarkers. Prospective controlled studies are needed to confirm these associations.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-19
DOI
https://doi.org/10.3389/fphar.2026.1777466
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Postoperative outcomes of drug-eluting sinus implants versus oral methylprednisolone after functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps

Baohua Hu, Jian-Miao Fang, Zhi-Hong Lin, Zhong-Hua Lu et al.
Frontiers in Pharmacology
Sinusitis and nasal conditions
article

Postoperative outcomes of drug-eluting sinus implants versus oral methylprednisolone after functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps

Baohua Hu, Jian-Miao Fang, Zhi-Hong Lin, Zhong-Hua Lu, Zhe Zhang
article en

Abstract

Background Drug-eluting sinus implants provide sustained local corticosteroid delivery after functional endoscopic sinus surgery (FESS), but comparative evidence relative to systemic corticosteroid therapy remains limited. This study aimed to compare postoperative outcomes between these strategies in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Methods This retrospective cohort included 129 patients treated between January 2022 and December 2024. Patients were classified into the drug-eluting sinus implant group, which underwent FESS with drug-eluting sinus implants (n = 68), and the oral methylprednisolone group, which underwent FESS followed by a 15-day oral methylprednisolone taper (n = 61). Both groups received the same routine postoperative care. The primary outcome was longitudinal change in the Sino-Nasal Outcome Test-22 (SNOT-22) score through Month 12. Secondary outcomes included visual analog scale (VAS) symptom scores, endoscopic healing outcomes, postoperative complications, and steroid-related adverse events. Biomarker changes were exploratory outcomes. Results SNOT-22 scores improved in both groups. At Month 12, the model-based between-group difference in change was −11.86 points (95% confidence interval [CI], −14.82 to −8.90; Holm-adjusted P < 0.001), with a similar multivariable-adjusted estimate (−11.32 points; 95% CI, −14.61 to −8.04; P < 0.001). Improvements in all five VAS symptom domains were greater in the drug-eluting sinus implant group after multiplicity correction. Compared with the oral methylprednisolone group, the drug-eluting sinus implant group had lower adjusted odds of synechiae or adhesion at Month 3 (adjusted odds ratio [OR], 0.09; 95% CI, 0.02–0.43) and ostial stenosis or obstruction at Month 6 (adjusted OR, 0.20; 95% CI, 0.06–0.65). Steroid-related adverse events occurred in 2.9% of patients in the drug-eluting sinus implant group and 16.4% of those in the oral methylprednisolone group (P = 0.013). Most inflammatory and type 2 biomarkers showed greater reductions at Month 3 in the drug-eluting sinus implant group after false discovery rate correction. Conclusion Compared with oral methylprednisolone, drug-eluting sinus implants was associated with greater symptom improvement, more favorable postoperative healing outcomes, fewer steroid-related adverse events, and greater reductions in several inflammatory biomarkers. Prospective controlled studies are needed to confirm these associations.

Frontiers in PharmacologyVol. 17
Ningbo No. 2 Hospital (CN), Ningbo University Affiliated Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Zhejiang University (CN)
Sinusitis and nasal conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon